SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $170,633 | +12.0% | 30,094 | +10.6% | 0.00% | – |
| Q4 2022 | $152,382 | +85.8% | 27,211 | +112.4% | 0.00% | – |
| Q3 2022 | $82,000 | +26.2% | 12,812 | -32.6% | 0.00% | – |
| Q2 2022 | $65,000 | -85.5% | 19,023 | -69.8% | 0.00% | – |
| Q1 2022 | $448,000 | -5.3% | 62,953 | +10.9% | 0.00% | – |
| Q4 2021 | $473,000 | +151.6% | 56,753 | +110.2% | 0.00% | – |
| Q3 2021 | $188,000 | -73.0% | 26,997 | -7.5% | 0.00% | -100.0% |
| Q2 2021 | $696,000 | -45.5% | 29,192 | -52.9% | 0.00% | -50.0% |
| Q1 2021 | $1,276,000 | +18.1% | 61,960 | +40.5% | 0.00% | 0.0% |
| Q4 2020 | $1,080,000 | +7100.0% | 44,097 | +2087.4% | 0.00% | – |
| Q1 2018 | $15,000 | -62.5% | 2,016 | -18.3% | 0.00% | – |
| Q3 2017 | $40,000 | – | 2,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |